サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684488

インフルエンザ診断の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）

Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 237 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
インフルエンザ診断の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年03月20日
発行: Persistence Market Research
ページ情報: 英文 237 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

重要考察

  • インフルエンザ診断の市場規模：18億330万米ドル（2025年）
  • 予測される市場金額：27億1,150万米ドル（2032年）
  • 世界市場の成長率：6.00%（2025年～2032年のCAGR）

インフルエンザ診断市場 - レポート範囲

インフルエンザ診断市場は、A型、B型、C型インフルエンザを含むインフルエンザウイルスの検出と同定に使用される診断ツールの開発と普及に焦点を当てています。この市場は、季節性インフルエンザとパンデミックインフルエンザの流行の増加、迅速で正確な診断検査に対する需要の増加、分子検査と血清学的検査の技術的進歩によって牽引されています。疾病の発生を抑制するための早期かつ正確な検出に対するニーズの高まりと、医療インフラへの投資の増加が、市場の拡大をさらに後押ししています。

市場成長の促進要因

世界のインフルエンザ診断市場は、世界のインフルエンザ感染負担の増加、疾病の早期発見に対する意識の高まり、診断技術の進歩など、複数の要因により大きな成長を示しています。政府や医療機関は、インフルエンザの監視と準備を重視しており、インフルエンザ診断検査の採用をさらに促進しています。さらに、ポイントオブケア検査への需要と分子診断法の拡大が市場成長を促進しています。

市場抑制要因

大きな成長が見込まれる一方、分子診断にかかる高いコストや、地域によっては先進の医療施設へのアクセスが限られていることなどの課題に直面しています。迅速診断検査（RIDT）の精度は、偽陰性の結果が適時の治療に影響を及ぼす可能性があるため、依然として懸念となっています。規制上のハードルや診断キットの厳しい承認プロセスも市場の拡大遅らせる可能性があります。

市場機会

インフルエンザ診断市場には、革新的な高感度検査ソリューションの開発や診断プラットフォームへのAIの統合など、大きな成長機会があります。新興市場への進出やポイントオブケア検査ソリューションへの投資は、市場への浸透を促進する可能性があります。さらに、診断メーカーと医療提供者との戦略的提携により、製品のアクセスや入手性が向上し、市場需要がさらに高まります。

当レポートでは、世界のインフルエンザ診断市場について調査し、成長促進要因、動向、機会、課題などの市場力学の詳細な分析を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲/分類
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主な市場動向

  • 市場に影響を与える主要動向
  • 製品のイノベーション/開発の動向

第4章 重要な成功要因

  • 製品の採用/利用の分析
  • 製品のUSP/特徴
  • 戦略とプロモーション戦略
  • 主な規制
  • 疾病の疫学
  • PESTLE分析
  • ポーターの分析

第5章 市場の背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 力学

第6章 COVID-19危機の分析

  • COVID-19と影響の分析
    • 検査別
    • インフルエンザタイプ別
    • エンドユーザー別
  • 市場シナリオ（2022年）

第7章 世界のインフルエンザ診断市場の見通し（2019年～2032年）

  • 市場金額の実績の分析（2019年～2024年）
  • 現在と将来の市場金額の予測（2025年～2032年）
    • 前年比成長動向の分析
    • 絶対的収益機会の分析

第8章 世界のインフルエンザ診断市場の見通し：検査別（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：検査別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：検査別（2025年～2032年）
    • 分子診断検査
    • 従来の診断検査
  • 市場の魅力分析：検査別

第9章 インフルエンザ診断市場の見通し：インフルエンザタイプ別（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：インフルエンザタイプ別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：インフルエンザタイプ別（2025年～2032年）
    • A型インフルエンザ
    • B型インフルエンザ
    • C型インフルエンザ
  • 市場の魅力分析：インフルエンザタイプ別

第10章 インフルエンザ診断市場の見通し：エンドユーザー別（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：エンドユーザー別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：エンドユーザー別（2025年～2032年）
    • 病院
    • 診断検査室
    • 研究・学術機関
    • 開発業務受託機関（CRO）
  • 市場の魅力分析：エンドユーザー別

第11章 インフルエンザ診断市場の見通し：地域別（2019年～2032年）

  • イントロダクション
  • 市場規模の実績の分析：地域別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：地域別（2025年～2032年）
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第12章 北米のインフルエンザ診断市場の見通し（2019年～2032年）

第13章 ラテンアメリカのインフルエンザ診断市場の見通し（2019年～2032年）

第14章 欧州のインフルエンザ診断市場の見通し（2019年～2032年）

第15章 南アジアのインフルエンザ診断市場の見通し（2019年～2032年）

第16章 東アジアのインフルエンザ診断市場の見通し（2019年～2032年）

第17章 オセアニアのインフルエンザ診断市場の見通し（2019年～2032年）

第18章 中東・アフリカのインフルエンザ診断市場の見通し（2019年～2032年）

第19章 市場構造分析

  • 市場の分析：企業のTier別
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合の詳細
    • Abbott Laboratories
    • Endress+Hauser (Analytik Jena AG)
    • Becton, Dickinson and Company
    • Biocartis
    • bioMerieux Inc
    • Danaher Corporation (Cepheid)
    • F. Hoffmann-La Roche Ltd
    • GenMark Diagnostics, Inc.
    • Luminex Corporation
    • Meridian Bioscience, Inc
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Hologic

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP13246

Persistence Market Research has recently released a comprehensive report on the global Influenza Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, enabling stakeholders to make well-informed decisions.

Key Insights:

  • Influenza Diagnostics Market Size (2025E): USD 1,803.30 Mn
  • Projected Market Value (2032F): USD 2,711.50 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.00%

Influenza Diagnostics Market - Report Scope:

The Influenza Diagnostics Market focuses on the development and adoption of diagnostic tools used to detect and identify influenza viruses, including influenza A, B, and C. The market is driven by the rising prevalence of seasonal and pandemic influenza, increasing demand for rapid and accurate diagnostic tests, and technological advancements in molecular and serological testing. The growing need for early and precise detection to curb disease outbreaks, along with increased investment in healthcare infrastructure, is further fueling market expansion.

Market Growth Drivers:

The global Influenza Diagnostics Market is experiencing significant growth due to multiple factors, including the increasing burden of influenza infections worldwide, rising awareness of early disease detection, and advancements in diagnostic technologies. Governments and healthcare organizations are emphasizing influenza surveillance and preparedness, further driving the adoption of influenza diagnostic tests. Additionally, the demand for point-of-care testing and the expansion of molecular diagnostic methods are propelling market growth.

Market Restraints:

Despite strong growth prospects, the market faces challenges such as high costs associated with molecular diagnostics and limited access to advanced healthcare facilities in certain regions. The accuracy of rapid diagnostic tests (RIDTs) remains a concern, as false-negative results can impact timely treatment. Regulatory hurdles and stringent approval processes for diagnostic kits may also slow market expansion.

Market Opportunities:

The Influenza Diagnostics Market presents substantial growth opportunities, including the development of innovative, high-sensitivity testing solutions and the integration of artificial intelligence (AI) in diagnostic platforms. Expansion into emerging markets and investments in point-of-care testing solutions can drive market penetration. Additionally, strategic collaborations between diagnostic manufacturers and healthcare providers will enhance product accessibility and affordability, further boosting market demand.

Key Questions Answered in the Report:

  • What are the major factors driving global growth in the Influenza Diagnostics Market?
  • How are molecular diagnostic advancements shaping the future of influenza testing?
  • Which diagnostic tests are witnessing the highest adoption rates?
  • Who are the key players in the Influenza Diagnostics Market, and what strategies are they implementing?
  • What are the emerging trends and market projections for influenza diagnostics?

Competitive Intelligence and Business Strategy:

Leading companies in the Influenza Diagnostics Market, such as Abbott Laboratories, Becton, Dickinson and Company, and Thermo Fisher Scientific Inc., are focusing on technological innovations, product launches, and strategic partnerships to strengthen their market presence. Companies are investing in molecular diagnostics, point-of-care testing, and AI-driven diagnostic solutions to enhance influenza detection accuracy and speed. Collaborations with research institutions and healthcare organizations help expand their market footprint and improve accessibility to advanced diagnostic solutions.

Key Companies Profiled:

  • Abbott Laboratories
  • Endress+Hauser (Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Hologic

Influenza Diagnostics Industry Research by Category:

By Test Type:

  • Molecular Diagnostic Test
  • Traditional Diagnostic Test
  • H1N1 Influenza A Virus Identification Kits
  • Immunoassay Kits
  • Immunofluorescence Antibody Assay

By Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Contract Research Organizations (CROs)

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic and Promotional Strategies
  • 4.4. Key Regulations
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Market Outlook
    • 5.1.3. Global Infectious Disease Diagnostics Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
    • 5.2.2. Application Innovation in Influenza Diagnostics
    • 5.2.3. Product Adoption Rate
    • 5.2.4. Regulatory Impositions
    • 5.2.5. Growing R&D Investments
    • 5.2.6. Novel Diagnostic Product Development Activities
    • 5.2.7. Awareness Campaigns for Influenza Diagnostics
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Test
    • 6.1.2. By Type of Flu
    • 6.1.3. By End User
  • 6.2. 2022 Market Scenario

7. Global Influenza Diagnostics Market Outlook, 2019-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Outlook, 2019-2032, By Test

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Test, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test, 2025-2032
    • 8.3.1. Molecular Diagnostics Tests
      • 8.3.1.1. RT-PCR
      • 8.3.1.2. LAMP
      • 8.3.1.3. NASABA
    • 8.3.2. Traditional Diagnostics Tests
      • 8.3.2.1. Rapid Influenza Detection Kits
      • 8.3.2.2. Serological Assays
      • 8.3.2.3. Direct Fluorescent Antibody
      • 8.3.2.4. Viral Culture
      • 8.3.2.5. H1N1 Influenza A Virus Identification Kits
      • 8.3.2.6. Immunoassay Kits
      • 8.3.2.7. Immunofluorescence Antibody Assay
  • 8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Outlook, 2019-2032, By Type of Flu

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Type of Flu, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of Flu, 2025-2032
    • 9.3.1. Type A Flu
    • 9.3.2. Type B Flu
    • 9.3.3. Type C Flu
  • 9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Outlook, 2019-2032, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Research & Academic Institutes
    • 10.3.4. Contract Research Organizations (CRO)
  • 10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Outlook, 2019-2032, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Outlook, 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Test
    • 12.3.3. By Type of Flu
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Test
    • 12.4.3. By Type of Flu
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Influenza Diagnostics Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Test
        • 12.5.1.2.2. By Type of Flu
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Influenza Diagnostics Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Test
        • 12.5.2.2.2. By Type of Flu
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis
  • 12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Outlook, 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Test
    • 13.3.3. By Type of Flu
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Test
    • 13.4.3. By Type of Flu
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Influenza Diagnostics Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Test
        • 13.5.1.2.2. By Type of Flu
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Influenza Diagnostics Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Test
        • 13.5.2.2.2. By Type of Flu
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Influenza Diagnostics Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Test
        • 13.5.3.2.2. By Type of Flu
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis
  • 13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Test
    • 14.3.3. By Type of Flu
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Test
    • 14.4.3. By Type of Flu
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Influenza Diagnostics Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Test
        • 14.5.1.2.2. By Type of Flu
        • 14.5.1.2.3. By End User
    • 14.5.2. France Influenza Diagnostics Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Test
        • 14.5.2.2.2. By Type of Flu
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Influenza Diagnostics Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Test
        • 14.5.3.2.2. By Type of Flu
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Influenza Diagnostics Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Test
        • 14.5.4.2.2. By Type of Flu
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Influenza Diagnostics Market Analysis
      • 14.5.5.1. Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Test
        • 14.5.5.2.2. By Type of Flu
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Influenza Diagnostics Market Analysis
      • 14.5.6.1. Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Test
        • 14.5.6.2.2. By Type of Flu
        • 14.5.6.2.3. By End User
    • 14.5.7. BENELUX Influenza Diagnostics Market Analysis
      • 14.5.7.1. Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Test
        • 14.5.7.2.2. By Type of Flu
        • 14.5.7.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis
  • 14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Outlook, 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Test
    • 15.3.3. By Type of Flu
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Test
    • 15.4.3. By Type of Flu
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Influenza Diagnostics Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Test
        • 15.5.1.2.2. By Type of Flu
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Influenza Diagnostics Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Test
        • 15.5.2.2.2. By Type of Flu
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Influenza Diagnostics Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Test
        • 15.5.3.2.2. By Type of Flu
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Influenza Diagnostics Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Test
        • 15.5.4.2.2. By Type of Flu
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Outlook, 2019 - 2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Test
    • 16.3.3. By Type of Flu
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Test
    • 16.4.3. By Type of Flu
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Influenza Diagnostics Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Test
        • 16.5.1.2.2. By Type of Flu
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Influenza Diagnostics Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Test
        • 16.5.2.2.2. By Type of Flu
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Influenza Diagnostics Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Test
        • 16.5.3.2.2. By Type of Flu
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Outlook, 2019-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Test
    • 17.3.3. By Type of Flu
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Test
    • 17.4.3. By Type of Flu
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Influenza Diagnostics Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Test
        • 17.5.1.2.2. By Type of Flu
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Influenza Diagnostics Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Test
        • 17.5.2.2.2. By Type of Flu
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Outlook, 2019 - 2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Test
    • 18.3.3. By Type of Flu
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Test
    • 18.4.3. By Type of Flu
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Test
        • 18.5.1.2.2. By Type of Flu
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkey Influenza Diagnostics Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Test
        • 18.5.2.2.2. By Type of Flu
        • 18.5.2.2.3. By End User
    • 18.5.3. South Africa Influenza Diagnostics Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Test
        • 18.5.3.2.2. By Type of Flu
        • 18.5.3.2.3. By End User
    • 18.5.4. North Africa Influenza Diagnostics Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Test
        • 18.5.4.2.2. By Type of Flu
        • 18.5.4.2.3. By End User
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Key Market Participants - Intensity Mapping
  • 18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Abbott Laboratories
      • 20.2.1.1. Overview
      • 20.2.1.2. Product Portfolio
      • 20.2.1.3. Key Financials
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. Strategy Overview
        • 20.2.1.5.1. Marketing Strategy
        • 20.2.1.5.2. Product Strategy
        • 20.2.1.5.3. Channel Strategy
    • 20.2.2. Endress+Hauser (Analytik Jena AG)
      • 20.2.2.1. Overview
      • 20.2.2.2. Product Portfolio
      • 20.2.2.3. Key Financials
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. Strategy Overview
        • 20.2.2.5.1. Marketing Strategy
        • 20.2.2.5.2. Product Strategy
        • 20.2.2.5.3. Channel Strategy
    • 20.2.3. Becton, Dickinson and Company
      • 20.2.3.1. Overview
      • 20.2.3.2. Product Portfolio
      • 20.2.3.3. Key Financials
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. Strategy Overview
        • 20.2.3.5.1. Marketing Strategy
        • 20.2.3.5.2. Product Strategy
        • 20.2.3.5.3. Channel Strategy
    • 20.2.4. Biocartis
      • 20.2.4.1. Overview
      • 20.2.4.2. Product Portfolio
      • 20.2.4.3. Key Financials
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. Strategy Overview
        • 20.2.4.5.1. Marketing Strategy
        • 20.2.4.5.2. Product Strategy
        • 20.2.4.5.3. Channel Strategy
    • 20.2.5. bioMerieux Inc
      • 20.2.5.1. Overview
      • 20.2.5.2. Product Portfolio
      • 20.2.5.3. Key Financials
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. Strategy Overview
        • 20.2.5.5.1. Marketing Strategy
        • 20.2.5.5.2. Product Strategy
        • 20.2.5.5.3. Channel Strategy
    • 20.2.6. Danaher Corporation (Cepheid)
      • 20.2.6.1. Overview
      • 20.2.6.2. Product Portfolio
      • 20.2.6.3. Key Financials
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. Strategy Overview
        • 20.2.6.5.1. Marketing Strategy
        • 20.2.6.5.2. Product Strategy
        • 20.2.6.5.3. Channel Strategy
    • 20.2.7. F. Hoffmann-La Roche Ltd
      • 20.2.7.1. Overview
      • 20.2.7.2. Product Portfolio
      • 20.2.7.3. Key Financials
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. Strategy Overview
        • 20.2.7.5.1. Marketing Strategy
        • 20.2.7.5.2. Product Strategy
        • 20.2.7.5.3. Channel Strategy
    • 20.2.8. GenMark Diagnostics, Inc.
      • 20.2.8.1. Overview
      • 20.2.8.2. Product Portfolio
      • 20.2.8.3. Key Financials
      • 20.2.8.4. Sales Footprint
      • 20.2.8.5. Strategy Overview
        • 20.2.8.5.1. Marketing Strategy
        • 20.2.8.5.2. Product Strategy
        • 20.2.8.5.3. Channel Strategy
    • 20.2.9. Luminex Corporation
      • 20.2.9.1. Overview
      • 20.2.9.2. Product Portfolio
      • 20.2.9.3. Key Financials
      • 20.2.9.4. Sales Footprint
      • 20.2.9.5. Strategy Overview
        • 20.2.9.5.1. Marketing Strategy
        • 20.2.9.5.2. Product Strategy
        • 20.2.9.5.3. Channel Strategy
    • 20.2.10. Meridian Bioscience, Inc
      • 20.2.10.1. Overview
      • 20.2.10.2. Product Portfolio
      • 20.2.10.3. Key Financials
      • 20.2.10.4. Sales Footprint
      • 20.2.10.5. Strategy Overview
        • 20.2.10.5.1. Marketing Strategy
        • 20.2.10.5.2. Product Strategy
        • 20.2.10.5.3. Channel Strategy
    • 20.2.11. Quidel Corporation
      • 20.2.11.1. Overview
      • 20.2.11.2. Product Portfolio
      • 20.2.11.3. Key Financials
      • 20.2.11.4. Sales Footprint
      • 20.2.11.5. Strategy Overview
        • 20.2.11.5.1. Marketing Strategy
        • 20.2.11.5.2. Product Strategy
        • 20.2.11.5.3. Channel Strategy
    • 20.2.12. Thermo Fisher Scientific Inc.
      • 20.2.12.1. Overview
      • 20.2.12.2. Product Portfolio
      • 20.2.12.3. Key Financials
      • 20.2.12.4. Sales Footprint
      • 20.2.12.5. Strategy Overview
        • 20.2.12.5.1. Marketing Strategy
        • 20.2.12.5.2. Product Strategy
        • 20.2.12.5.3. Channel Strategy
    • 20.2.13. Hologic
      • 20.2.13.1. Overview
      • 20.2.13.2. Product Portfolio
      • 20.2.13.3. Key Financials
      • 20.2.13.4. Sales Footprint
      • 20.2.13.5. Strategy Overview
        • 20.2.13.5.1. Marketing Strategy
        • 20.2.13.5.2. Product Strategy
        • 20.2.13.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology